Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02061449 · ClinicalTrials.gov registry record · Phase 1
Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma
A Phase 1 study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT02061449: Clinical Trial Phase 1 study, sponsored by NYU Langone Health.
NCT02061449 is a Phase 1 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02061449, a Phase 1 study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study evaluates the safety and tolerability of the addition of immunostimulatory therapy consisting of focal radiation with or without the Toll-like receptor (TLR) agonist Poly ICLC in patients with cutaneous T-cell lymphoma (CTCL) receiving concurrent therapy with the histone deacetylase inhibitor (HDACI) Romidepsin.
Primary Outcome
Adverse events and dose-limiting toxicities will be graded using National Cancer Institute's Common Toxicity Criteria for Adverse Effects (CTCAE) 4.0.
Interventions
- DRUG Poly ICLC
- DRUG Romidepsin
- RADIATION Focal lesional radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-03 |
| Est. Completion | 2018-11-05 |
| Phase | Phase 1 |
Why NCT02061449 stopped before completion
NCT02061449 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Poly ICLC is the first listed.
NCT02061449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02061449 about?
NCT02061449 is a clinical study titled "Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma". This study evaluates the safety and tolerability of the addition of immunostimulatory therapy consisting of focal radiation with or without the Toll-like receptor (TLR) agonist Poly ICLC in patients with cutaneous T-cell lymphoma (CTCL) receiving concurrent therapy with the histone deacetylase inhib...
What is the current status of trial NCT02061449?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2014-03. Estimated completion is 2018-11-05.
What interventions are being tested in trial NCT02061449?
The interventions under investigation include: Poly ICLC (DRUG), Romidepsin (DRUG), Focal lesional radiation (RADIATION).
Who is sponsoring clinical trial NCT02061449?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02061449's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia